Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression

Blood (2021) 138 (Supplement 1): 800.

https://doi.org/10.1182/blood-2021-148645

Published: 2021

Journal Articles

Tumor suppressor function of Gata2 in acute promyelocytic leukemia

Casey D. S. Katerndahl, Olivia R. S. Rogers, Ryan B. Day, Michelle A. Cai, Timothy P. Rooney, Nichole M. Helton, Mieke Hoock, Sai Mukund Ramakrishnan, Sridhar Nonavinkere Srivatsan, Lukas D. Wartman, Christopher A. Miller, Timothy J. Ley

Blood (2021) 138 (13): 1148–1161.

https://doi.org/10.1182/blood.2021011758

Published: 2021

Includes: Supplemental data

Journal Articles

B-Cell Acute Lymphoblastic Leukemia Arising in Patients with a Preexisting Diagnosis of Multiple Myeloma Is a Novel Cancer with High Incidence of TP53 Mutations

Monique Chavez, BS, Erica Barnell, BS, Malachi Griffith, PhD, Zachary Skidmore, Obi Griffith, Ling Tian, PhD, Lukas D Wartman, MD

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-142067

Published: 2020

Journal Articles

The Loss of Kdm6a in B-Cell Development Causes Germinal Center Hyperplasia and Impedes the B-Cell Immune Response in a Specific Manner

Ling Tian, PhD, Monique Chavez, BS, Lukas D Wartman, MD

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-142107

Published: 2020

Journal Articles

The Complex Role of KDM6A in B-Cell Development and Function

Ling Tian, PhD, Monique Chavez, B.S., Lukas D Wartman, MD

Blood (2018) 132 (Supplement 1): 513.

https://doi.org/10.1182/blood-2018-99-119538

Published: 2018

Journal Articles

Improving Risk Assessment of AML with a Precision Genomic Strategy to Assess Mutation Clearance

Blood (2018) 132 (Supplement 1): 5277.

https://doi.org/10.1182/blood-2018-99-114979

Published: 2018

Journal Articles

Expression of the Tumor Suppressor WT1 Is Induced By PML-Rara in Acute Promyelocytic Leukemia.Â Â

Matt Christopher, MD PhD, Andrew Menssen, Margery Gang, Anand Upadhyaya, Lukas D Wartman, MD, Timothy James J Ley, MD

Blood (2017) 130 (Supplement 1): 2508.

https://doi.org/10.1182/blood.V130.Suppl_1.2508.2508

Published: 2017

Journal Articles

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

Blood (2017) 130 (Supplement 1): 2678.

https://doi.org/10.1182/blood.V130.Suppl_1.2678.2678

Published: 2017

Journal Articles

The Role of Kdm6a in Malignant Hematopoiesis

Ling Tian, PhD, Lukas D Wartman, MD

Blood (2017) 130 (Supplement 1): 1227.

https://doi.org/10.1182/blood.V130.Suppl_1.1227.1227

Published: 2017

Journal Articles

Generation and Characterization of Murine Allogeneic T Cell Resistant APL Cells

Ezhilarasi Chendamarai, PhD, Michael P Rettig, PhD, Gue Su Chang, PhD, Allegra A Petti, PhD, Christopher A Miller, PhD, Julie Ritchey, Lukas D Wartman, MD, Timothy J Ley, MD, John F DiPersio, MD PhD

Blood (2017) 130 (Supplement 1): 3170.

https://doi.org/10.1182/blood.V130.Suppl_1.3170.3170

Published: 2017

Journal Articles

Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

Blood (2017) 129 (10): 1397–1401.

https://doi.org/10.1182/blood-2016-10-745273

Published: 2017

Includes: Supplemental data

Journal Articles

The Role of Kdm6a in Normal Hematopoiesis

Ling Tian, PhD, Lukas D. Wartman, MD

Blood (2016) 128 (22): 1467.

https://doi.org/10.1182/blood.V128.22.1467.1467

Published: 2016

Journal Articles

Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

Matt Christopher, MD PhD, Allegra A. Petti, PhD, Christopher Miller, PhD, Lukas D. Wartman, MD, Jacqueline E. Payton, MD PhD, Sharon Heath, Robert Fulton, John S. Welch, MD PhD, Matthew J. Walter, MD, Peter Westervelt, MD PhD, Daniel C. Link, MD, Richard K Wilson, PhD, Timothy J. Ley, MD, John F. DiPersio, MD, PhD

Blood (2016) 128 (22): 1528.

https://doi.org/10.1182/blood.V128.22.1528.1528

Published: 2016

Journal Articles

Exome Sequencing of Hodgkin's and Non-Hodgkin Composite Lymphomas Identifies Shared Somatic Mutations Indicative of Common Founding Precursors

Felicia Gomez, PhD, Matthew Matlock, BA, Kilannin Krysiak, PhD, Yi-Shan Lee, MD, Eric J. Duncavage, MD, Michelle O'Laughlin, BS, Malachi Griffith, PhD, Todd A Fehniger, MD PhD, Lukas D. Wartman, MD, Obi L. Griffith, PhD

Blood (2016) 128 (22): 5285.

https://doi.org/10.1182/blood.V128.22.5285.5285

Published: 2016

Journal Articles

Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia

Stephen T. Oh, MD PhD, Christopher A. Miller, PhD, Yevgeniy Gindin, PhD, Taylor M. Brost, Jason Chan, MD PhD, Mary C. Fulbright, Daniel A.C. Fisher, PhD, Eric J. Duncavage, MD, Michelle O'Laughlin, Malachi Griffith, PhD, Obi L. Griffith, PhD, Lukas D. Wartman, MD

Blood (2016) 128 (22): 5496.

https://doi.org/10.1182/blood.V128.22.5496.5496

Published: 2016

Journal Articles

Deleterious Germline Mutations in Telomere Maintenance Genes Identified in a Subset of Patients with Myelodysplastic Syndrome and Idiopathic Pulmonary Fibrosis

Kilannin Krysiak, PhD, Meagan A. Jacoby, MD PhD, Zachary L. Skidmore, MS, Arpad M. Danos, PhD, Michelle O'Laughlin, BS, Eric J. Duncavage, MD, Matthew J. Walter, MD, Malachi Griffith, PhD, Obi L. Griffith, PhD, Lukas D. Wartman, MD

Blood (2016) 128 (22): 4306.

https://doi.org/10.1182/blood.V128.22.4306.4306

Published: 2016

Journal Articles

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Blood (2015) 126 (23): 689.

https://doi.org/10.1182/blood.V126.23.689.689

Published: 2015

Journal Articles

The Targeted Disruption of Kdm6a/Utx in Mice Has Gender-Dependent Effects on Primitive Hematopoietic Cell Populations and Myeloid Progenitors

Ling Tian, PhD, Lukas D. Wartman, MD

Blood (2015) 126 (23): 1158.

https://doi.org/10.1182/blood.V126.23.1158.1158

Published: 2015

Journal Articles

A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia

Lukas D. Wartman, MD, Mark A. Fiala, BS, CCRP, Emily Hawkins, BS, Theresa Fletcher, MS, Melissa Allen, Amanda F. Cashen, MD, John F. DiPersio, MD PhD, Meagan Jacoby, MD PhD, Keith E. Stockerl-Goldstein, MD, Iskra Pusic, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MBBS, MD

Blood (2014) 124 (21): 5292.

https://doi.org/10.1182/blood.V124.21.5292.5292

Published: 2014

Journal Articles

DNA Sequencing of a Murine Acute Promyelocytic Leukemia (APL) Genome Using Next Generation Technology.

Lukas D. Wartman, MD, Li Ding, David E. Larson, Michael D. McLellan, Heather Schmidt, Zhifu Xiang, MD, PhD, Michael Tomasson, MD, Elaine Mardis, PhD, Richard K. Wilson, PhD, Timothy J. Ley, MD

Blood (2009) 114 (22): 3965.

https://doi.org/10.1182/blood.V114.22.3965.3965

Published: 2009

NARROW

Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression

Tumor suppressor function of Gata2 in acute promyelocytic leukemia

B-Cell Acute Lymphoblastic Leukemia Arising in Patients with a Preexisting Diagnosis of Multiple Myeloma Is a Novel Cancer with High Incidence of TP53 Mutations

The Loss of Kdm6a in B-Cell Development Causes Germinal Center Hyperplasia and Impedes the B-Cell Immune Response in a Specific Manner

The Complex Role of KDM6A in B-Cell Development and Function

Improving Risk Assessment of AML with a Precision Genomic Strategy to Assess Mutation Clearance

Expression of the Tumor Suppressor WT1 Is Induced By PML-Rara in Acute Promyelocytic Leukemia.Â Â

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

The Role of Kdm6a in Malignant Hematopoiesis

Generation and Characterization of Murine Allogeneic T Cell Resistant APL Cells

Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

The Role of Kdm6a in Normal Hematopoiesis

Clonal Evolution of Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

Exome Sequencing of Hodgkin's and Non-Hodgkin Composite Lymphomas Identifies Shared Somatic Mutations Indicative of Common Founding Precursors

Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia

Deleterious Germline Mutations in Telomere Maintenance Genes Identified in a Subset of Patients with Myelodysplastic Syndrome and Idiopathic Pulmonary Fibrosis

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

The Targeted Disruption of Kdm6a/Utx in Mice Has Gender-Dependent Effects on Primitive Hematopoietic Cell Populations and Myeloid Progenitors

A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia

DNA Sequencing of a Murine Acute Promyelocytic Leukemia (APL) Genome Using Next Generation Technology.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only